Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
11.63
-0.21 (-1.82%)
At close: Jun 27, 2025, 4:00 PM
11.65
+0.03 (0.22%)
After-hours: Jun 27, 2025, 7:09 PM EDT
Stoke Therapeutics Employees
Stoke Therapeutics had 128 employees as of December 31, 2024. The number of employees increased by 18 or 16.36% compared to the previous year.
Employees
128
Change (1Y)
18
Growth (1Y)
16.36%
Revenue / Employee
$1,491,469
Profits / Employee
$392,750
Market Cap
634.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
STOK News
- 10 days ago - Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 12 days ago - Stoke Therapeutics: Impressive Pipeline And Big Backers - Seeking Alpha
- 4 weeks ago - Stoke Therapeutics to Present at the Jefferies Global Healthcare Conference - Business Wire
- 6 weeks ago - Stoke Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates - Business Wire
- 3 months ago - Stoke Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference - Business Wire
- 3 months ago - Stoke Therapeutics Stock Slips as CEO Steps Down - Investopedia
- 3 months ago - Stoke Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates - Business Wire
- 3 months ago - Stoke Therapeutics Announces CEO Transition - Business Wire